Corpus Intelligence IC Memo — MIDWESTERN REGIONAL MEDICAL CENTER 2026-04-26 02:14 UTC
IC Memo — MIDWESTERN REGIONAL MEDICAL CENTER
Investment Committee Memorandum | IL | 73 beds | Grade B | EBITDA uplift $101.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MIDWESTERN REGIONAL MEDICAL CENTER

CCN 140100 | LAKE, IL | 73 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

MIDWESTERN REGIONAL MEDICAL CENTER is a 73-bed suburban community hospital in LAKE, IL with $1.38B in net patient revenue and a 80.5% operating margin. The hospital serves a payer mix of 30.0% Medicare, 1.4% Medicaid, and 68.6% commercial.

Thesis: Turnaround. Our ML models identify $101.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 80.5% to 87.8% (+736bps).

Net Revenue HCRIS$1.38B
Current EBITDA COMPUTED$1.11B
Operating Margin COMPUTED80.5%
Occupancy HCRIS15.8%
Revenue / Bed COMPUTED$19.0M
Net-to-Gross HCRIS63.4%
Distress Probability ML33.6%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
69
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 80.5% places it above the state median. Among 69 size-comparable peers (36-146 beds), the median margin is -9.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-146), prioritizing same-state peers. 69 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MIDWESTERN REGIONAL MEDICAL CE (Target)IL73$1.38B80.5%
NORTHWESTERN LAKE FOREST HOSPIIL124$494.3M-13.8%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
KISHWAUKEE COMMUNITY HOSPITALIL98$355.3M25.5%
ST. ELIZABETH HOSPITALIL144$296.2M-3.2%
CGH MEDICAL CENTERIL95$247.1M-7.6%
SSM HEALTH GOOD SAMARITAN HOSPIL111$214.8M1.5%
MORRIS HOSPITALIL89$210.8M1.7%
ADVENTIST BOLINGBROOK HOSPITALIL110$199.3M-5.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $101.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$29.1M+210bp18mo
Cost to Collect4.5%2.5%$27.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$27.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$16.8M+122bp9mo
Clean Claim Rate88.0%96.0%$886K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$29.1M
Cost to Collect
$27.7M
Denial Rate Reduction
$27.4M
A/R Days Reduction
$16.8M
Clean Claim Rate
$886K
Total EBITDA Uplift$101.9M
Current EBITDA$1.11B
+ RCM Uplift+$101.9M
Pro Forma EBITDA$1.22B
Current Margin80.5%
Pro Forma Margin87.8%
WC Released (1x)$53.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.71B$8.36B4.88x37.3%
Base (11x exit)10.0x11.0x$1.71B$9.76B5.70x41.6%
Bull Case9.0x11.0x$1.54B$10.65B6.91x47.2%
Bull (12x exit)9.0x12.0x$1.54B$12.07B7.83x50.9%
Bear Case11.0x10.0x$1.88B$7.30B3.87x31.1%
Bear (11x exit)11.0x11.0x$1.88B$8.64B4.58x35.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 15.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 69 hospitals with 36-146 beds
  • Same-state prioritization (n=70)
  • Comp margins: P25=-22.3% / P50=-9.5% / P75=1.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.